Clinical Observation on Bufei Tongluo Wan Combined with Methotrexate for Rheumatoid Arthritis Associated Early Interstitial Lung Disease: A 32 Cases Report
XIE Yujie. Clinical Observation on Bufei Tongluo Wan Combined with Methotrexate for Rheumatoid Arthritis Associated Early Interstitial Lung Disease: A 32 Cases Report[J]. Journal of Traditional Chinese Medicine2011, 52(14): 1213-1216.
XIE Yujie. Clinical Observation on Bufei Tongluo Wan Combined with Methotrexate for Rheumatoid Arthritis Associated Early Interstitial Lung Disease: A 32 Cases Report[J]. Journal of Traditional Chinese Medicine2011, 52(14): 1213-1216.DOI: 10.13288/j.11-2166/r.2011.14.029.
Objective To observe the effect and safety of Bufei Tongluo Wan (Bolus for tonifying the lung and removing obstruction of meridians) combined with methotrexate on rheumatoid arthritis associated interstitial lung disease (RA-ILD) in an early stage.Methods Sixty-four patients were randomized into two groups with 32 in each.The observation group was treated with Bufei Tongluo Wan and methotrexate for oral taking
while the control group treated with methotrexate only in continuation.After treatment for six months
the indices of lung function and changes in high resolution computer tomography (HRCT) of both groups were compared to observe the effect.Results After treatment
the total lung capacity (TLC) and diffusing capacity carbon monoxide (DLCO) of the observation group were significantly improved (P<0.01); and its HRCT score was reduced (P<0.05).The result of TLC
DLCO
and HRCT of the two groups in comparison after treatment showed statistical difference (P<0.01 or P<0.05).Conclusion Bufei Tongluo Wan combined with methotrexate in the treatment of RA-ILD in an early stage is effective in improving the lung function and decreasing the area of interstitial lung lesions with a good safety.